ER-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with ER-Positive Breast Cancer — Part 3

Featuring perspectives from Dr Kevin Kalinsky, including the following topics: Introduction (0:00) Journal Club with Dr Kalinsky (1:08) Case: A woman in her mid-60s with ER-positive, PR-negative, HER2-negative metastatic breast cancer (mBC) — Ann Partridge, MD, MPH (17:55) Case: A woman in her early 30s with ER/PR-positive, HER2-negative mBC with a PIK3CA mutation — Arielle Heeke, MD (23:40) Case: A woman in her mid-40s with ER/PR-positive, HER2-negative, node-positive localized breast cancer who had HER2-positive disease after neoadjuvant therapy — Debra Patt, MD, PhD, MBA (30:39) Case: A woman in her early 60s with ER-positive, HER2-negative, node-positive breast cancer — Dhatri Kodali, MD (35:38) Case: A woman in her late 70s with Stage IIIC ER/PR-positive, HER2-negative breast cancer — Rahul Gosain, MD (38:47) Case: A woman in her late 40s with ER/PR-positive, HER2-negative mBC — Ranju Gupta, MD (51:15) San Antonio Breast Cancer Symposium® 2021 Preview (53:51) Beyond the Guidelines (55:57) CME information and select publications